Notably, the amplification of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in NAD synthesis, underscores its pivotal role in sustaining NAD-dependent metabolic pathways essential for cancer cell survival. This evidence concerns the gene NAMPT and cancer.